$0.00
Cancer Times gives an overview of a pharmaceutical firm's ad campaign that urged healthy women to assess their breast-cancer risks. Author reports on how the National Cancer Institute "deliberately concealed risk information during the Food and Drug Administration approval process."
Looks like you haven't made a choice yet.
